PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jmedcasrepBioMed Centralsearchsubmit a manuscriptregisterthis articleJournal of Medical Case ReportsJournal of Medical Case Reports
 
J Med Case Reports. 2010; 4: 78.
Published online Mar 3, 2010. doi:  10.1186/1752-1947-4-78
PMCID: PMC2838916
Mycosis fungoides bullosa: a case report and review of the literature
Hermann Kneitz,corresponding author1 Eva-B Bröcker,1 and Jürgen C Becker1
1Department of Dermatology, Julius-Maximilians University, Josef-Schneider-Str. 2, 97080 Wuerzburg, Germany
corresponding authorCorresponding author.
Hermann Kneitz: Kneitz_H/at/klinik.uni-wuerzburg.de; Eva-B Bröcker: Broecker_E/at/klinik.uni-wuerzburg.de; Jürgen C Becker: Becker_jc/at/klinik.uni-wuerzburg.de
Received March 30, 2008; Accepted March 3, 2010.
Introduction
Mycosis fungoides, the most common type of cutaneous T-cell lymphoma, can manifest in a variety of clinical and histological forms. Bulla formation is an uncommon finding in mycosis fungoides and only approximately 20 cases have been reported in the literature.
Case presentation
We present a case of rapidly progressive mycosis fungoides in a 68-year-old Caucasian man who initially presented with erythematous plaques characterised by blister formation.
Conclusion
Although mycosis fungoides bullosa is extremely rare, it has to be regarded as an important clinical subtype of cutaneous T-cell lymphoma. Mycosis fungoides bullosa represents a particularly aggressive form of mycosis fungoides and is associated with a poor prognosis. The rapid disease progression in our patient confirms bulla formation as an adverse prognostic sign in cutaneous T-cell lymphoma.
Introduction
Mycosis fungoides, the most common type of cutaneous T-cell lymphoma, can manifest in a variety of clinical and histological forms, but blistering is not a feature normally associated with the condition. Indeed, of the many variants that have been reported in the literature, approximately 20 cases of the bullous variant have been described.
A 68-year-old Caucasian man presented for evaluation of two indurated erythematous plaques (9 × 8 cm and 8 × 5 cm) on his left thigh (Figure (Figure1A);1A); within these plaques, intact bullae and erosions were present. The condition had persisted for several years with a slow growth in diameter and thickness despite topical therapy with potent steroids. Notably, the patient reported several fugacious episodes of blistering within and in the vicinity of these plaques; these episodes had occurred with increasing frequency over the preceding months. The general examination results were otherwise unremarkable. In particular, neither lymphadenopathy nor organomegaly were present. Histological examination of these lesions revealed subcorneal and intra-epidermal bullae accompanied by infiltrates of atypical lymphocytes. The latter were characterised by a marked epidermotropism and the formation of Pautrier microabscesses (Figure (Figure1B).1B). Immunohistochemical analysis revealed the infiltrate to be predominantly T cells (CD3+, CD20-). Direct (Figure (Figure1C)1C) and indirect immunofluorescence as well as bacterial and fungal cultures were negative.
Figure 1
Figure 1
Mycosis fungoides presentation, and histological and immunohistochemical examinations. (a) Bullous lesions are present on two indurated erythematous plaques on the left thigh. (b) Histopathologic section showing subcorneal and intra-epidermal bullae accompanied (more ...)
Initial treatment of our patient with electron beam irradiation led to complete clearance, but after 1 year, generalised erythematous plaques of mycosis fungoides bullosa appeared on his trunk and extremities without lymph node and visceral involvement. Further electron beam irradiation was carried out.
The most common causes of acquired bulla formation on inflamed skin areas are acute contact dermatitis as well as infections with Staphylococci, or viruses of the herpes group. Bullous lichen planus or bullous lupus erythematosus are rare diseases, whereas bullous pemphigoid is the most common autoimmune bullous disorder [1].
In mycosis fungoides, bulla formation is very uncommon. Approximately 20 cases have been reported in the literature [2,3]. Mycosis fungoides bullosa is largely restricted to older patients without predominance of gender. Predilection sites are the trunk and limbs. Vesicles and blisters usually arise in typical plaques and tumours but also in normal-appearing skin [2,4].
An association with concomitant bullous pemphigoid or previous treatment with psoralen UVA photochemotherapy has been reported [5]. Bowman et al. proposed the following criteria for diagnosis of mycosis fungoides bullosa [2]: (1) clinically apparent vesiculobullous lesions; (2) typical histologic features of mycosis fungoides (atypical lymphoid cells, epidermotropism, Pautrier's microabscesses) with intra-epidermal or subepidermal blisters; (3) negative immunofluorescence ruling out concomitant autoimmune bullous diseases; and (4) negative evaluation for other possible causes of vesiculobullous lesions (for example, medications, bacterial or viral infection, porphyria, phototherapy).
The pathological mechanism underlying blister formation has not been elucidated. Confluence of Pautrier's microabscesses in mycosis fungoides lesions may lead to intra-epidermal bulla formation [6]. Alternatively, proliferation of neoplastic lymphocytes may result in a loss of coherence between basal keratinocytes and basal lamina [7] or the cohesion of keratinocytes may be affected by the release of lymphokines by atypical lymphocytes [8].
Conclusions
Although mycosis fungoides bullosa is extremely rare, it has to be regarded as an important clinical subtype of cutaneous T-cell lymphoma. Mycosis fungoides bullosa represents an especially aggressive form of mycosis fungoides associated with a poor prognosis. Approximately 50% of patients die within 1 year after the appearance of the blistering of the lymphoma plaques [1,9].
Consent
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors contributed in the management of the patient, writing of the manuscript and reviewing the literature. All authors read and approved the final manuscript.
  • Bertram F, Bröcker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges. 2009;13:379–387. [PubMed]
  • Bowman PH, Hogan DJ, Sanusi ID. Mycosis fungoides bullosa: report of a case and review of the literature. J Am Acad Dermatol. 2001;45:934–939. doi: 10.1067/mjd.2001.117521. [PubMed] [Cross Ref]
  • Gantcheva M, Lalova A, Broshtilova V, Negenzova Z, Tsankov N. Vesicular mycosis fungoides. J Dtsch Dermatol Ges. 2005;3:898–900. doi: 10.1111/j.1610-0387.2005.05739.x. [PubMed] [Cross Ref]
  • Ho KK, Browne A, Fitzgibbons J, Carney D, Powell FC. Mycosis fungoides bullosa simulating pyoderma gangrenosum. Br J Dermatol. 2000;142:124–127. doi: 10.1046/j.1365-2133.2000.03253.x. [PubMed] [Cross Ref]
  • Patterson J, Ali M, Murray J, Hatra T. Bullous pemphigoid: occurrence in patient with mycosis fungoides receiving PUVA and topical mustard therapy. Int J Dermatol. 1985;24:173–176. [PubMed]
  • Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18:397–415. doi: 10.1111/j.1468-3083.2004.00937.x. [PubMed] [Cross Ref]
  • Konrad K. In: Lymphoproliferative Diseases of the Skin. Christophers E, Goos M, editor. New York: Springer Verlag; 1979. Mycosis fungoides bullosa; pp. 157–162.
  • Kartsonis J, Brettschneider F, Weissmann A, Rosen L. Mycosis fungoides bullosa. Am J Dermatopathol. 1990;12:76–80. [PubMed]
  • McBride S, Dahl M, Slater D, Sviland L. Vesicular mycosis fungoides. Br J Dermatol. 1998;138:141. doi: 10.1046/j.1365-2133.1998.02041.x. [PubMed] [Cross Ref]
Articles from Journal of Medical Case Reports are provided here courtesy of
BioMed Central